Finzati - Logo
ACXP logo

Acurx Pharmaceuticals, Inc.

ACXP • Biotechnology
$1.42
▲ +0.02 (+1.43%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$6.00M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 3.18Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:20 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$1.42
Change1.43%
Market Cap$6.00M
52W Range1.31 - 8.34
Beta-2.03
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio3.18
Quick Ratio3.18
Volume604.70K

Investment DNA

How strong this company looks for long-term investors

40
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
58/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 3.18Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 6/25/2021
Industry: Biotechnology
P/B i: 0.71
Debt / Equity i: 0.00
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.00
Current Ratio: 3.18
Quick Ratio: 3.18
Status: Good

Insider Transactions

Recent executive and insider activity

Shawah Robert G.
Transaction: 04/20/2026
BUY
Change
+25,900
Price
$2.36
Filing
04/22/2026
Type
BUY
LUCI DAVID P
Transaction: 04/20/2026
BUY
Change
+37,100
Price
$2.36
Filing
04/22/2026
Type
BUY
DELUCCIA ROBERT J
Transaction: 04/20/2026
BUY
Change
+37,100
Price
$2.36
Filing
04/22/2026
Type
BUY